355 related articles for article (PubMed ID: 29085213)
1. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma.
Li B; Xiong XZ; Zhou Y; Wu SJ; You Z; Lu J; Cheng NS
World J Gastroenterol; 2017 Sep; 23(36):6685-6693. PubMed ID: 29085213
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma.
Peng D; Lu J; Hu H; Li B; Ye X; Cheng N
J Gastrointest Surg; 2020 Feb; 24(2):330-340. PubMed ID: 30671792
[TBL] [Abstract][Full Text] [Related]
5. Relationship between serum MMP-9 level and prognosis after radical resection for Hilar cholangiocarcinoma patients.
Li O; Yi W; Yang P; Guo C; Peng C
Acta Cir Bras; 2019 Apr; 34(4):e201900409. PubMed ID: 31038586
[TBL] [Abstract][Full Text] [Related]
6. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
[TBL] [Abstract][Full Text] [Related]
7. Intraductal ultrasonography combined with percutaneous transhepatic cholangioscopy for the preoperative evaluation of longitudinal tumor extent in hilar cholangiocarcinoma.
Kim HM; Park JY; Kim KS; Park MS; Kim MJ; Park YN; Bang S; Song SY; Chung JB; Park SW
J Gastroenterol Hepatol; 2010 Feb; 25(2):286-92. PubMed ID: 19780880
[TBL] [Abstract][Full Text] [Related]
8. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors.
Kimura N; Young AL; Toyoki Y; Wyatt JI; Toogood GJ; Hidalgo E; Prasad KR; Kudo D; Ishido K; Hakamada K; Lodge JPA
Surgery; 2017 Sep; 162(3):500-514. PubMed ID: 28551378
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors of early recurrence after R0 resection of hilar cholangiocarcinoma: A single institution experience in China.
Hu HJ; Jin YW; Shrestha A; Ma WJ; Wang JK; Liu F; Zhu YY; Zhou RX; Regmi P; Cheng NS; Li FY
Cancer Med; 2019 Apr; 8(4):1567-1575. PubMed ID: 30868740
[TBL] [Abstract][Full Text] [Related]
10. High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.
Higuchi R; Yazawa T; Uemura S; Izumo W; Furukawa T; Yamamoto M
J Hepatobiliary Pancreat Sci; 2017 Aug; 24(8):456-465. PubMed ID: 28547855
[TBL] [Abstract][Full Text] [Related]
11. Hilar cholangiocarcinoma: Value of high-resolution enhanced magnetic resonance imaging for preoperative evaluation.
Xin Y; Liu Q; Zhang J; Lu J; Song X; Zhan H; Chen X; Cao Z; Li Y; Huang Z
J Cancer Res Ther; 2020; 16(7):1634-1640. PubMed ID: 33565510
[TBL] [Abstract][Full Text] [Related]
12. Surgical resection for hilar cholangiocarcinoma: experience improves resectability.
Cannon RM; Brock G; Buell JF
HPB (Oxford); 2012 Feb; 14(2):142-9. PubMed ID: 22221577
[TBL] [Abstract][Full Text] [Related]
13. Assessment of clinical outcomes of advanced hilar cholangiocarcinoma.
Chen KJ; Yang FC; Qin YS; Jin J; Zheng SS
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):155-162. PubMed ID: 29636302
[TBL] [Abstract][Full Text] [Related]
14. The clinicopathological factors associated with prognosis of patients with resectable perihilar cholangiocarcinoma: A systematic review and meta-analysis.
Tang Z; Yang Y; Zhao Z; Wei K; Meng W; Li X
Medicine (Baltimore); 2018 Aug; 97(34):e11999. PubMed ID: 30142840
[TBL] [Abstract][Full Text] [Related]
15. [Klatskin's tumors].
Bertelsen CA; Burcharth F
Ugeskr Laeger; 2005 Apr; 167(14):1525-30. PubMed ID: 15887750
[No Abstract] [Full Text] [Related]
16. [New criteria of radical surgery and long-term outcomes of hilar cholangiocarcinoma management].
Kovalenko YA; Vishnevsky VA; Chzhao AV; Zharikov YO
Khirurgiia (Mosk); 2018; (8):4-11. PubMed ID: 30113586
[TBL] [Abstract][Full Text] [Related]
17. A modified Jarnagin-Blumgart classification better predicts survival for resectable hilar cholangiocarcinoma.
Ding G; Yang Y; Cao L; Chen W; Wu Z; Jiang G
World J Surg Oncol; 2015 Mar; 13():99. PubMed ID: 25889726
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
[TBL] [Abstract][Full Text] [Related]
19. Clinical Implications of Biliary Confluence Pattern for Bismuth-Corlette Type IV Hilar Cholangiocarcinoma Applied to Hemihepatectomy.
Ji GW; Zhu FP; Wang K; Jiao CY; Shao ZC; Li XC
J Gastrointest Surg; 2017 Apr; 21(4):666-675. PubMed ID: 28168674
[TBL] [Abstract][Full Text] [Related]
20. Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.
Chen P; Li B; Zhu Y; Chen W; Liu X; Li M; Duan X; Yi B; Wang J; Liu C; Luo X; Li X; Li J; Liang L; Yin X; Wang H; Jiang X
Oncotarget; 2016 Jun; 7(24):37319-37330. PubMed ID: 27144432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
